Eli Lilly and Company

Total Lobbying Efforts: 57

All Officials
Select methods...

Lobbying Records (Page 1 of 6)

2026-05-20
1 official
Politician(s) lobbied: Muiris O’Connor (Assistant Secretary), Department of Health
Intent: To request a meeting with a senior Lilly scientist visiting from the US, on the topic of scientific research and innovation.
Methods: Email
Details by Method
Method not specified
Emerging trends in scientific research.
2026-05-20
10 officials
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment; Simon Harris (Tánaiste and Minister), Department of Finance; John Hogan (Secretary General), Department of Finance; Declan Hughes (Secretary General), Department of Enterprise, Trade and Employment; Ken O'Flynn (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Martin Daly (TD), Dáil Éireann, the Oireachtas; Maria Byrne (Senator), Seanad; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas
Intent: To raise awareness amongst stakeholders of the importance of policy cohesion and a whole-of-government approach in the development of the National Life Sciences Strategy, to ensure that Ireland has a competitive policy landscape for the life sciences sector into the future.
Methods: Event / ReceptionInformal communicationMeeting
Details by Method
Method not specified
National Life Sciences Strategy
2026-04-30
1 official
Politician(s) lobbied: Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas
Intent: To see the government quickly engage in negotiations on a new framework agreement for the supply of innovative medicines for patients in Ireland, and to inform the government of the importance of the valuing medicines innovation at all stages of the pharmaceutical value-chain.
Methods: Phone call
Details by Method
Method not specified
IPHA Framework Agreement for the Supply of Innovative Medicines.
2025-09-19
1 official
Politician(s) lobbied: John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment
Intent: To highlight the need for European policies that promote investment in scientific research and development, and manufacturing of innovative medicines in Europe, through strong protection of intellectual property rights.
Methods: EmailMeeting
Details by Method
Method not specified
Advocate for improved EU policy environment to support continued investment in medicines innovation and manufacturing
2025-09-19
3 officials
Politician(s) lobbied: Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs; Joseph Hackett (Secretary General), Department of Foreign Affairs
Intent: To highlight the complexity of global supply chains in the pharmaceutical industry and the risk of disruption those supply chains that tariffs may cause. ::To highlight the need for pro-business government policies that value innovation and support the continued strong footprint of innovative biopharma manufacturing in Ireland.
Methods: Virtual Meeting
Details by Method
Method not specified
Discuss the risks of potential tariffs on the complex global supply chains for innovative medicines
2025-05-21
2 officials
Politician(s) lobbied: John Callinan (Secretary General), Department of the Taoiseach; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment
Intent: To highlight importance of maintaining EU competitiveness for global pharmaceutical investment in research, development & manufacturing through protection of IP rights & balanced environmental regulation in EU,
Methods: Meeting
Details by Method
Method not specified
Highlight importance of maintaining EU competitiveness
2025-05-21
3 officials
Politician(s) lobbied: Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs
Intent: To highlight the need for European policies that promote investment in scientific research and development, and manufacturing of innovative medicines in Europe, through strong protection of intellectual property rights and balanced environmental regulation including PFAS, Urban Waste Water Treatment Directive. ::To highlight the importance of reliable global supply chains in the pharmaceutical industry and the risk of tariffs to the disruption those supply chains.
Methods: Event / ReceptionPhone call
Details by Method
Method not specified
Advocate for improved EU Environment to support investment in medicines innovation and manufacturing
2025-01-21
23 officials
Politician(s) lobbied: Regina Doherty (MEP), European Parliament; Kathleen Funchion (MEP), European Parliament; Seán Kelly (MEP), European Parliament; Michael McGrath (Minister), Department of Finance; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Michael McNamara (MEP), European Parliament; Patrick O'Donovan (Minister), Department of Further and Higher Education, Research, Innovation and Science; Kieran O'Donnell (Minister of State), The Office of Public Works; Niall Collins (Minister of State), Department of Further and Higher Education, Research, Innovation and Science; Maurice Quinlivan (TD), Dáil Éireann, the Oireachtas; Brian Leddin (TD), Dáil Éireann, the Oireachtas; Richard O'Donoghue (TD), Dáil Éireann, the Oireachtas; Willie O'Dea (TD), Dáil Éireann, the Oireachtas; Maria Byrne (Senator), Seanad; Paul Gavan (Senator), Seanad; Joe Carey (TD), Dáil Éireann, the Oireachtas; Cathal Crowe (TD), Dáil Éireann, the Oireachtas; Violet Anne Wynne (TD), Dáil Éireann, the Oireachtas; Martin Conway (Senator), Seanad; Timmy Dooley (Senator), Seanad; Róisín Garvey (Senator), Seanad; John Moran (Mayor of Limerick), Limerick City and County Council; Billy Kelleher (MEP), European Parliament
Intent: To update policymakers/stakeholders on Lilly's investment in strategic manufacturing operations in Limerick and Kinsale; to highlight key policy areas of importance for Lilly's continued growth in both Ireland and across the EU, including advocating for EU legislative reform that ensures equal and timely access to innovations for all patients across Europe and the strengthening of legislative protections for intellectual property rights.
Methods: EmailLetterMeetingPhone call
Details by Method
Method not specified
Update on company operations in Ireland and EU
2024-09-20
1 official
Politician(s) lobbied: Michael McGrath (TD), Dáil Éireann, the Oireachtas
Intent: To seek government support/funding for an joint proposal developed by University of Limerick and some biopharma companies in Ireland for a new Immersive Masters Programme ('iBio') 4-year degree programme
Methods: EmailInformal communication
Details by Method
Method not specified
Government funding for third level education programme in STEM
2024-09-20
15 officials
Politician(s) lobbied: Moira Murrell (Chief Executive Officer), Cork County Council; Loraine Lynch (Acting Divisional Manager), Cork County Council; Padraig Barrett (Director of Services or Equivalent), Cork County Council; Sharon Corcoran (Director of Services or Equivalent), Cork County Council; Tim Lombard (Senator), Seanad; Jerry Buttimer (Senator), Seanad; Holly Cairns (TD), Dáil Éireann, the Oireachtas; Michael Collins (TD), Dáil Éireann, the Oireachtas; Christopher O'Sullivan (TD), Dáil Éireann, the Oireachtas; Simon Coveney (TD), Dáil Éireann, the Oireachtas; Donnchadh Ó Laoghaire (TD), Dáil Éireann, the Oireachtas; Denis O'Donovan (Senator), Seanad; Billy Kelleher (MEP), European Parliament; Kathleen Funchion (MEP), European Parliament; Cynthia Ní Mhurchú (MEP), European Parliament
Intent: Invitation to corporate event at Lilly Kinsale to raise awareness of economic impact of Lilly's continued manufacturing site investment.
Methods: Email
Details by Method
Method not specified
Investment and Economic Impact of Lilly Kinsale.